Unaudited Preliminary Results for the year ended 31 March 2023

Creating a valuable and differentiated Drug Delivery Platform

25 May 2023:  ReNeuron Group plc (AIM: RENE), a UK based leader in stem cell derived exosome technologies, announces its unaudited preliminary results for the year ended 31 March 2023.

Read more…

Back